75259-79-9 Usage
Uses
Used in Pharmaceutical Industry:
5-CHLORO-3-[2-(4-PYRIDINYL)ETHYL]-INDOLE is used as a pharmaceutical candidate for the development of new drugs due to its potential biological activities and pharmacological applications. Its specific interactions and effects within biological systems are still under investigation, which may lead to the discovery of new treatments for various medical conditions.
Used in Research and Development:
5-CHLORO-3-[2-(4-PYRIDINYL)ETHYL]-INDOLE is used as a research compound for studying its potential biological activities and pharmacological applications. Further research on 5-CHLORO-3-[2-(4-PYRIDINYL)ETHYL]-INDOLE may contribute to the understanding of its interactions and effects within biological systems, potentially leading to the development of new drugs for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 75259-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,2,5 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 75259-79:
(7*7)+(6*5)+(5*2)+(4*5)+(3*9)+(2*7)+(1*9)=159
159 % 10 = 9
So 75259-79-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H13ClN2/c16-13-3-4-15-14(9-13)12(10-18-15)2-1-11-5-7-17-8-6-11/h3-10,18H,1-2H2
75259-79-9Relevant academic research and scientific papers
3-(4-Piperidinylalkyl)indoles, Selective Inhibitors of Neuronal 5-Hydroxytryptamine Uptake
Gueremy, Claude,Audiau, Francois,Champseix, Alain,Uzan, Andre,Fur, Gerard Le,Rataud, Jean
, p. 1306 - 1310 (2007/10/02)
A series 3-(4-piperidinylalkyl)indoles was synthesized and tested as uptake inhibitors of biogenic amines.Some of these compounds are potent and very selective in blocking the 5-hydroxytryptamine (5-HT) uptake, as evidenced by biochemical data and behavioral tests.A discussion on structure-activity relationships is given.The most interesting member of the series, indalpine, 3-indole (1), was selected for clinical studies.
